AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $129,000 | -62.1% | 44,901 | -50.0% | 0.00% | -100.0% |
| Q2 2021 | $340,000 | +466.7% | 89,793 | +403.3% | 0.00% | – |
| Q1 2021 | $60,000 | -61.0% | 17,841 | -67.4% | 0.00% | – |
| Q4 2020 | $154,000 | +234.8% | 54,712 | +197.3% | 0.00% | – |
| Q3 2020 | $46,000 | -89.8% | 18,400 | -44.7% | 0.00% | -100.0% |
| Q2 2020 | $452,000 | +59.7% | 33,300 | -11.0% | 0.00% | +50.0% |
| Q1 2020 | $283,000 | +444.2% | 37,400 | +255.9% | 0.00% | – |
| Q2 2019 | $52,000 | -62.3% | 10,510 | -27.5% | 0.00% | -100.0% |
| Q1 2018 | $138,000 | +1433.3% | 14,500 | +1379.6% | 0.00% | – |
| Q3 2015 | $9,000 | – | 980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |